Submission   16,619


Advertisement

About

Arknights is a Chinese mobile tower-defense game developed by Hypergryph. In the game, the player controls an unseen "Doctor," who commands a squad of "operators" in an attempt to stem a growing plague. The game has been praised for its high production quality and emphasis on lore.

History

The game was in development in China and began growing popular after a Promotional Video released in September of 2017 (shown below).



In China, the game went into closed beta on December 1st, 2017.[3] _Arknights_' international release was teased in December of 2018[1] (trailer shown below).


The game released internationally late January of 2020,[2] with a preview appearing on the iOS App Store on January 15th, and the game releasing the next day. In the game, the player controls a doctor and controls operators, generally moe girls, as they attempt to stem a plague of "Originium." Players can select which fighters they will bring into battle to stop invaders from reaching their defenses. It is free-to-play with Gacha mechanics, with fighters unlocked randomly or purchasable with real currency.

Reception

Arknights was praised upon its international release. Pocket Gamer[4] wrote that though one might not initially understand why a mobile tower defense game was so popular, the amount of lore and attention to detail made the game look like "the coolest thing ever." The game has a 4.5/5 rating on Google Play based on over 11,000 votes.[5]

Online Presence

Arknights has developed a strong international online presence. On Reddit, the /r/Arknights[6] subreddit has over 47,000 members. The game's English Twitter account has over 58,000 followers.[7] The game has been featured in several popular Let's Play videos, including a video by The Next Hokage that gained over 100,000 views (shown below, left) and another by Tectone that gained over 85,000 views (shown below, right).


Search Interest

External References



Share Pin

Recent Images 276 total


Recent Videos 3 total




Load 20 Comments
See more